AKT1 and glioblastoma: (43–45) found that THEM 4 acts as an endogenous inhibitor of protein kinase B (PKB/Akt) in glioblastoma, which preferentially binds phosphorylated Akt and blocks downstream signaling by eliminating Akt activity and phosphorylation.